David Protein has raised $75 million in Series A funding to acquire food-tech company Epogee, aiming to enhance its supply chain and product innovation amid legal challenges.
Information on the Target
David Protein, an emerging brand in the protein bar market, has successfully raised $75 million in Series A funding. This capital will be utilized to acquire Epogee, a food-tech company recognized for its innovative plant-based fat alternative, EPG. The acquisition is part of David Protein's strategy to enhance its supply chain and foster product innovation, thereby positioning itself more competitively in the food and nutrition sector.
Epogee's EPG has the ability to reduce calories from fat by up to 92%, allowing food manufacturers, including David Protein, to deliver higher protein content without the addition of sugars. Following the acquisition, Epogee will continue its operations as an independent entity, receiving logistical, manufacturing, and regulatory support from David Protein.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target's Specific Country
The protein bar market has seen significant growth in recent years, driven by increasing consumer demand for healthy snack options and protein-rich foods. This market is characterized by a diverse range of product
Similar Deals
S2G Investments → Bettani Foods
2025
Longfellow Park Ventures, LLC → Puraclenz Holdings Inc.
2024
Ahimsa Foundation → Eat Just
2024
General Atlantic → Athletic Brewing Company
2024
David Protein
invested in
Epogee
in 2024
in a Series A deal
Disclosed details
Transaction Size: $75M
Revenue: $140M